Taking hormone replacement therapy to cope with the menopause 'cuts risk of common infections' 

Researchers from the University of Texas, in Dallas, found that women who take hormone replacement therapy are less at risk of contracting urinary tract infections
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

MONDAY, July 20, 2020 -- Hormone replacement therapy (HRT) might be able to break the cycle of recurring urinary tract infections in some women, a new study reports. Women taking HRT for symptoms of menopause tend to have a greater variety of...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
We present a large-scale study exploring factors defining urinary microbiome composition in community-dwelling older adult women without clinically active infection. Using 1,600 twins, we estimate the contribution of genetic and environmental factors to microbiome variation. The urinary microbiome is distinct from nearby sites and unrelated to stool microbiome with more Actinobacteria, Fusobacteria and Proteobacteria, but fewer Bacteroidetes, Firmicutes and Verrumicrobia. A quarter of variants had heritability estimates greater than 10% with most heritable microbes having potential clinical relevance, including Escherichia...
Source: Cell Host and Microbe - Category: Microbiology Authors: Tags: Cell Host Microbe Source Type: research
This review article explores the occurrence of urinary tract infection in women – in pregnancy, in gynaecology, after menopause as well as those that are acquired in hospitals. It discusses the pathophysiology of these infections and the evidence that is currently present for different management modalities. It also discusses in-depth, the various causes and treatment modalit ies for recurrent urinary tract infections including the burden that it can bear on women and society.
Source: Obstetrics, Gynaecology and Reproductive Medicine - Category: OBGYN Authors: Tags: Review Source Type: research
Date: August 10, 2020 Issue #:  1604Summary:  The primary symptoms of menopause are genitourinary (genitourinary syndrome of menopause; GSM) and vasomotor (VMS). Vulvovaginal atrophy can cause vaginal burning, irritation and dryness, dyspareunia, and dysuria, and increase the risk of urinary tract infections. Vasomotor symptoms ( " hot flashes " ) cause daytime discomfort and night sweats that may disrupt sleep. Hormone therapy is the most effective treatment for both genitourinary and vasomotor symptoms.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Activella acupuncture Alora Angeliq Antidepressants bazedoxifene Bijuva Bioidentical Hormones Brisdelle Climara Combi-Patch Ditropan Divigel Drospirenone Duavee Duavive Dyspareunia Effexor Elestrin Escitalopram Estr Source Type: research
To review the available data related to the prevention of recurrent urinary tract infection (rUTI) in postmenopausal women with vaginal estrogen preparations and provide the urologic community with the confidence to identify and treat genitourinary syndrome of menopause (GSM).
Source: Urology - Category: Urology & Nephrology Authors: Source Type: research
Conclusion: No clear association exists between polypropylene MUS placement and subsequent urethral diverticulum formation. Factors that diminish polypropylene mesh biocompatibility include elevated BMI, menopause, recurrent UTIs, prior pelvic surgeries, and preexisting medical conditions. Symptoms associated with urethral diverticula should prompt a complete urologic workup prior to MUS placement. PMID: 32462011 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
ConclusionAlthough there are many causes of recurrent urinary tract infections, this study showed that vaginal pH imbalance and labia minora anatomy in the lower third prominence based on the Banwell classification (type 3) were among the most important causes. Thus, we think that the vaginal anatomy should be evaluated in recurrent UTI patients.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research
Conditions:   Urinary Tract Infections;   Menopause Intervention:   Sponsor:   Hadassah Medical Organization Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
AbstractPurpose of ReviewThe purpose of this review article is to summarize the recent literature regarding the effect of hormone replacement therapy on pelvic floor disorders and its role as a preventative or treatment option.Recent FindingsThe recent evidence describing the effect of hormone replacement therapy on pelvic floor disorders is mainly limited to cohort studies, systematic reviews, and secondary analysis of randomized controlled trials such as the Women ’s Health Initiative and Nurses’ Health Study. There are few quality randomized controlled trials, especially within the last 5 years on this ...
Source: Current Bladder Dysfunction Reports - Category: Urology & Nephrology Source Type: research
This study also found that Proteus DNA, a genus with many uropathogenic species (Drzewiecka, 2016), was more prevalent in women with OAB compared to asymptomatic controls (Curtiss et al., 2017). IC A recent study by Abernethy et al. suggested that the microbiome may play a role in IC (Abernethy et al., 2017). In this study, 16S rRNA analysis determined the microbiome of catheterized urine from women (n = 40) with IC was not dominated by a single genus and was less likely to contain Lactobacillus compared to asymptomatic women. Abernethy et al. also showed that L. acidophilus was associated with less severe scores on the ...
Source: Frontiers in cellular and infection microbiology - Category: Microbiology Source Type: research
More News: Health | Hormone Replacement Therapy | Hormones | Men | Menopause | Texas University | Urinary Tract Infections | Women